About Aanjaay Industries Limited
Data last updated:
Aanjaay Industries Limited is a public limited company based in Indore, Madhya Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 22 August 1989 and has been in existence for over 37 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN L02423MP1989PLC005438. The company has 1 GST registration on record, which is no longer active. It is a listed company as per MCA records. Its shares are listed on BSE: 524322.
The company has an authorised share capital of ₹40 Cr and a paid-up capital of ₹23.71 Cr. It was formerly known as Kabra Drugs Limited. It is led by directors including Nanjappan Aravind (Managing Director) and Kuniamuthur Nanjappan Anand.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2026. The registered office is at Indore, Madhya Pradesh.
As per the latest standalone financials for FY 2025-26, the company reported a revenue of ₹92.74 Cr. For the same year it recorded a net profit of ₹4.95 Cr (net margin 5.3%) and EBITDA of ₹5.33 Cr (EBITDA margin 5.7%). The net worth stands at ₹29.62 Cr (up 20.1% YoY). Total assets are valued at ₹30.18 Cr (up 20.3% YoY).
The company has about 37 employees on its provident fund (EPFO) records.
As per MCA filings, the company has satisfied charges of ₹1.99 Cr on record. Court records list 20 cases involving the company, including 7 filed by the company and 13 filed against it; 4 cases are pending. The company has 33 deals on record (33 market trades); the latest was in September 2020. Its 3 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 1 larger and 2 smaller; the largest is Syglak Laboratories Private Limited with revenue of ₹64.04 Lakh.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website kabradrugs.com.
Company details
CIN history
Aanjaay Industries has one previous CIN (Corporate Identification Number): U02423MP1989PLC005438. The current CIN is L02423MP1989PLC005438, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L02423MP1989PLC005438 | Current |
| U02423MP1989PLC005438 | Previous |
Contact details
Aanjaay Industries Limited's registered office is in Indore, Madhya Pradesh. Its website is kabradrugs.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address208 Swadesh Bhavan, 2 Press Complex Ab Road, Indore, Madhya Pradesh, India – 452011
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Aanjaay Industries Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Aanjaay Industries Limited
FY 2025-26 filings availableAanjaay Industries Limited reported revenue of ₹92.74 Cr for FY 2025-26.
Financial Highlights
FY 2025-26 · StandaloneRevenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 92.74 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EBITDA | 5.33 | (1.72) | (0.73) | (0.34) | (0.18) | (0.15) | (0.05) |
| EBITDA margin | +5.8% | - | - | - | - | - | - |
| Profit before tax | 5.72 | (1.09) | (0.73) | (0.33) | (0.19) | (0.18) | (0.06) |
| Net profit | 4.95 | (1.09) | (0.73) | (0.33) | (0.19) | (0.18) | (0.06) |
| Net profit margin | +5.3% | - | - | - | - | - | - |
| EPS (₹) | 2.09 | (0.46) | (1.68) | (0.77) | (0.42) | (0.41) | (0.14) |
| Balance sheet | |||||||
| Total assets | 30.18 | 25.09 | 2.79 | 0.65 | 0.63 | 0.69 | 0.62 |
| Net worth | 29.62 | 24.66 | 1.08 | (0.73) | (0.39) | (0.21) | (0.03) |
| Total debt | 0.57 | 0.44 | 1.71 | 1.38 | 1.03 | 0.90 | 0.65 |
| Cash & bank | 10.58 | 21.30 | 2.67 | 0.00 | 0.00 | 0.01 | 0.01 |
| Net working capital | 27.85 | 24.53 | 2.77 | 0.63 | 0.60 | 0.65 | 0.55 |
| Cash flow | |||||||
| Cash from operations | (9.46) | (4.71) | (0.21) | (0.35) | (0.13) | (0.25) | (0.05) |
| Cash from investing | (1.36) | (0.05) | 0.00 | 0.00 | 0.00 | 0.00 | 0.06 |
| Cash from financing | 0.10 | 23.39 | 2.88 | 0.36 | 0.13 | 0.25 | (0.02) |
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 31.95 | 46.22 | 35.41 | 30.42 | 19.76 | 7.15 | 0.00 | 0.00 |
| Revenue growth (YoY) | +61.7% | +546.4% | - | - | - | - | - | - |
| Other income | 0.00 | 0.08 | 0.11 | 0.18 | 0.18 | 0.02 | 0.64 | 0.00 |
| Total expenses | 29.36 | 43.43 | 34.07 | 27.99 | 17.73 | 7.66 | 0.24 | 0.53 |
| EBITDA | 2.59 | 2.79 | 1.34 | 2.43 | 2.03 | (0.51) | (0.24) | (0.53) |
| EBITDA margin | +8.1% | +6.0% | +3.8% | +8.0% | +10.3% | -7.1% | - | - |
| Depreciation | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 | 0.00 | 0.01 | 0.00 |
| Interest | 0.00 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 2.57 | 2.84 | 1.42 | 2.60 | 2.20 | (0.49) | 0.39 | (0.53) |
| Tax | 0.65 | 0.72 | 0.36 | 0.04 | 0.37 | 0.00 | 0.00 | 0.00 |
Financial Statements
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 31.95 | 46.22 | 35.41 | 30.42 | 19.76 | 7.15 | 0.00 | 0.00 |
| Revenue growth (YoY) | +61.7% | +546.4% | - | - | - | - | - | - |
| Other income | 0.00 | 0.08 | 0.11 | 0.18 | 0.18 | 0.02 | 0.64 | 0.00 |
| Total expenses | 29.36 | 43.43 | 34.07 | 27.99 | 17.73 | 7.66 | 0.24 | 0.53 |
| EBITDA | 2.59 | 2.79 | 1.34 | 2.43 | 2.03 | (0.51) | (0.24) | (0.53) |
| EBITDA margin | +8.1% | +6.0% | +3.8% | +8.0% | +10.3% | -7.1% | - | - |
| Depreciation | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 | 0.00 | 0.01 | 0.00 |
| Interest | 0.00 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 2.57 | 2.84 | 1.42 | 2.60 | 2.20 | (0.49) | 0.39 | (0.53) |
| Tax | 0.65 | 0.72 | 0.36 | 0.04 | 0.37 | 0.00 | 0.00 | 0.00 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 92.74 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other income | 0.49 | 0.64 | 0.00 | 0.01 | 0.00 | 0.00 | 0.02 |
| Total expenses | 87.41 | 1.72 | 0.73 | 0.34 | 0.18 | 0.15 | 0.05 |
| Employee cost | 1.47 | 0.69 | 0.40 | 0.23 | 0.09 | 0.05 | 0.00 |
| EBITDA | 5.33 | (1.72) | (0.73) | (0.34) | (0.18) | (0.15) | (0.05) |
| EBITDA margin | +5.8% | - | - | - | - | - | - |
| Depreciation | 0.07 | 0.01 | 0.00 | 0.00 | 0.01 | 0.03 | 0.03 |
| Interest | 0.03 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 5.72 | (1.09) | (0.73) | (0.33) | (0.19) | (0.18) | (0.06) |
| Tax | 0.77 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net profit | 4.95 | (1.09) | (0.73) | (0.33) | (0.19) | (0.18) | (0.06) |
| Net profit margin | +5.3% | - | - | - | - | - | - |
| EPS (₹) | 2.09 | (0.46) | (1.68) | (0.77) | (0.42) | (0.41) | (0.14) |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 23.71 | 23.71 | 4.39 | 4.39 | 4.39 | 4.39 | 4.39 |
| Reserves & surplus | 5.91 | 0.95 | (5.86) | (5.12) | (4.78) | (4.60) | (4.42) |
| Shareholders' funds (net worth) | 29.62 | 24.66 | 1.08 | (0.73) | (0.39) | (0.21) | (0.03) |
| Secured loans | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Unsecured loans | 0.57 | 0.44 | 1.71 | 1.38 | 1.03 | 0.90 | 0.65 |
| Total debt | 0.57 | 0.44 | 1.71 | 1.38 | 1.03 | 0.90 | 0.65 |
| Total liabilities | 30.18 | 25.09 | 2.79 | 0.65 | 0.63 | 0.69 | 0.62 |
| Assets | |||||||
| Gross block | 0.92 | 0.05 | 0.00 | 0.00 | 0.00 | 0.17 | 0.17 |
| Net block | 0.84 | 0.04 | 0.00 | 0.00 | 0.00 | 0.01 | 0.04 |
| Capital work in progress | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventories | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sundry debtors | 70.78 | 0.60 | 0.60 | 0.60 | 0.60 | 1.25 | 1.25 |
| Cash & bank balances | 10.58 | 21.30 | 2.67 | 0.00 | 0.00 | 0.01 | 0.01 |
| Loans & advances | 2.61 | 2.77 | 1.28 | 0.08 | 0.10 | 0.10 | 0.08 |
| Total current assets | 83.97 | 24.67 | 4.55 | 0.68 | 0.70 | 1.36 | 1.34 |
| Total current liabilities | 56.12 | 0.14 | 1.78 | 0.05 | 0.10 | 0.71 | 0.79 |
| Net working capital | 27.85 | 24.53 | 2.77 | 0.63 | 0.60 | 0.65 | 0.55 |
| Total assets | 30.18 | 25.09 | 2.79 | 0.65 | 0.63 | 0.69 | 0.62 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 21.30 | 2.67 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 |
| Net cash from operating activities | (9.46) | (4.71) | (0.21) | (0.35) | (0.13) | (0.25) | (0.05) |
| Net cash from investing activities | (1.36) | (0.05) | 0.00 | 0.00 | 0.00 | 0.00 | 0.06 |
| Net cash from financing activities | 0.10 | 23.39 | 2.88 | 0.36 | 0.13 | 0.25 | (0.02) |
| Net change in cash | (10.72) | 18.63 | 2.67 | 0.00 | (0.01) | 0.00 | 0.00 |
| Closing cash | 10.58 | 21.30 | 2.67 | 0.00 | 0.00 | 0.01 | 0.01 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| EBITDA growth | +409.9% | -135.6% | -114.7% | -88.9% | -20.0% | -200.0% | - |
| PBT growth | +9998.0% | -49.3% | -121.2% | -73.7% | -5.6% | -200.0% | +62.5% |
| Net income growth | +554.1% | -49.3% | -121.2% | -73.7% | -5.6% | -200.0% | - |
| Revenue CAGR (3Y) | - | - | - | - | - | -100.0% | -100.0% |
| EBITDA CAGR (3Y) | - | +112.2% | +69.5% | +89.5% | +11.5% | -57.7% | - |
| Profitability & leverage | |||||||
| Net income margin | +5.3% | - | - | - | - | - | - |
| Return on capital employed | +20.1% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Return on net worth | +17.6% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Debt / equity | 0.02 | 0.08 | 8.83 | 0.00 | 0.00 | 0.00 | 0.00 |
| Long-term debt / equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest cover | 0.57 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency & per share | |||||||
| Fixed asset turnover | 191.22 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventory turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debtors turnover | 2.60 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS (₹) | 2.09 | (0.46) | (1.68) | (0.77) | (0.42) | (0.41) | (0.14) |
| Dividend per share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Book value per share (₹) | 12.49 | 10.40 | (3.34) | (1.67) | (0.90) | (0.47) | (0.06) |
To see the full year-wise statements and ratios of Aanjaay Industries Limited, buy the company report.
Board of directors of Aanjaay Industries Limited
Aanjaay Industries has 6 current directors and 20 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kuniamuthur Nanjappan Anand Also directs: Drushya Entertainment Broadcast Streams Limited | Director | 09 Jun 2022 | 4 Years 5 Months | Current |
| Anand Anitha | Director | 14 Jul 2022 | 4 Years 3 Months | Current |
| Ritu Tiwari | Director | 08 Oct 2025 | 1 Years 1 Months | Current |
| Nikita Sinha | Director | 08 Oct 2025 | 1 Years 1 Months | Current |
| Nanjappan Aravind | Managing Director | 14 Aug 2024 | 2 Years 2 Months | Current |
| Monam Kapoor Also directs: Lorenzini Apparels Limited, Plaza Wires Limited, Wonder Electricals Limited and 5 more | Additional Director | 21 Apr 2026 | 0 Years 6 Months | Current |
Peer comparison
Aanjaay Industries Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Aanjaay Industries Limitedthis company | ₹92.74 Cr (FY 2026) | ₹4.95 Cr | 5.3% | Indore, Madhya Pradesh, India | ||
| Syglak Laboratories Private Limited | ₹64.04 Lakh (FY 2017) | -75.0% | Badlapur, Maharashtra, India | |||
| Insora Healthcare Private Limited | ₹63.96 Lakh (FY 2024) | 53.0% | Kolkata, West Bengal, India | |||
| Vidi Laboratries Private Limited | ₹63.93 Lakh (FY 2025) | 10.0% | Vadodara, Gujarat, India |
To see the full peer comparison of Aanjaay Industries Limited, buy the company report.
Auditor
Aanjaay Industries Limited is audited by RISHI SEKHRI AND ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RISHI SEKHRI AND ASSOCIATES | FY 2023 | 128216W |
Shareholding
Shareholding for the quarter ended Mar 2026: promoters hold 0.00%, foreign institutional investors hold 0.00%, domestic institutional investors hold 0.00% and retail and other public shareholders hold 100.00%.
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | |
|---|---|---|---|---|
| Promoters | 0.00% | 0.00% | 0.00% | 0.00% |
| Public | 100.00% | 100.00% | 100.00% | 100.00% |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 31 Dec 2014 | 10555725 | Religare Finvest Limited | ₹1.51 Cr | Satisfied | |
| 13 Nov 2010 | 10250160 | Bank of India | ₹48 Lakh | Satisfied |
To see the full charge records of Aanjaay Industries Limited, buy the company report.
Total charge records: 2 View all charges
Deals & funding
Aanjaay Industries Limited has 33 deals on record (33 market trades); the latest was in September 2020.
Deals on record (5 of 33)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Sep 2020 | Market trade | ₹80,000 | Buyer: an individual |
| Jan 2016 | Market trade | ₹9.3 Lakh | Buyer: NBN Fintrade Private Limited Seller: NBN Fintrade Private Limited |
| Sep 2015 | Market trade | ₹2.6 Lakh | Buyer: NBN Fintrade Private Limited Seller: NBN Fintrade Private Limited |
| Jan 2015 | Market trade | ₹35.5 Lakh | Buyer: Pliris Capital Private Limited Seller: Pliris Capital Private Limited |
| Dec 2014 | Market trade | ₹18 Lakh | Seller: Mallinath Shares and Stock Private Limited |
To see the full deal history of Aanjaay Industries Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Aanjaay Industries Limited has 20 court cases on record: 7 filed by Aanjaay Industries, 13 filed against it. 4 cases are pending and 16 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 13 | 13 | 3 |
| High courts | 6 | 0 | 1 |
| Supreme Court | 1 | 0 | 0 |
Cases on record (5 of 20)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court | Court case (REVP) | Filed by the company against Chhattisgarh Medical Services Corporation Ltd. and 1 other | Disposed |
| High Court | Writ petition | Filed by the company against Chhattisgarh Medical Services Corporation Ltd. and 1 other | Disposed |
| Supreme Court | Court case (9999-Other) | Filed by the company against M/S. New India Assurance Co. Ltd. | Disposed |
| District court, Chandigarh | Court case (SUCC) | Filed against the company by an individual | Pending |
| District court, Jalgaon, Maharashtra | Court case (NDPS. S. Case) | Filed against the company by State | Pending |
To see the full case history of Aanjaay Industries Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Aanjaay Industries Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Aanjaay Industries has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Aanjaay Industries Limited, buy the company report.
Recent activity
Aanjaay Industries Limited has 40 board changes on record since 1989: 23 appointments and 17 cessations. The latest: Monam Kapoor was appointed as Additional Director on 21 Apr 2026.
35 earlier events are in the company report.
News
Frequently asked questions
Aanjaay Industries is an active public limited company based in Indore, Madhya Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 22 August 1989 (37+ years old) and is registered under CIN L02423MP1989PLC005438. Listed on BSE: 524322.
Aanjaay Industries reported revenue of ₹92.74 Cr for FY 2025-26 based on standalone financials.
Aanjaay Industries has 6 current directors:
- Nanjappan Aravind - Managing Director
- Kuniamuthur Nanjappan Anand - Director
- Anand Anitha - Director
- Ritu Tiwari - Director
- Nikita Sinha - Director
- Monam Kapoor - Additional Director
The latest financial statements of Aanjaay Industries on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
No. Aanjaay Industries has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Aanjaay Industries is L02423MP1989PLC005438. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Yes. Aanjaay Industries is a listed company as per MCA records. Its shares are listed on BSE (code: 524322).
Aanjaay Industries has 20 court cases on record: 7 filed by the company and 13 filed against it. 4 are pending. Most are in the district courts.
Aanjaay Industries was incorporated on 22 August 1989, making it 37+ years old. It is registered with the Registrar of Companies, Gwalior.
Aanjaay Industries has 33 deals on record (33 market trades); the latest was in September 2020.
The peers of Aanjaay Industries by revenue are Syglak Laboratories Private Limited, Insora Healthcare Private Limited, Vidi Laboratries Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
